tACS for Aphasia After Stroke
What You Need to Know Before You Apply
What is the purpose of this trial?
This study is evaluating whether a type of electrical stimulation may help improve language recovery for individuals who have had a stroke.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
Is tACS safe for humans?
While specific safety data for tACS (transcranial alternating current stimulation) is not provided in the research articles, similar non-invasive brain stimulation methods like tDCS (transcranial direct current stimulation) and rTMS (repetitive transcranial magnetic stimulation) have shown an excellent safety profile in studies for aphasia after stroke.12345
How does the tACS treatment for aphasia after stroke differ from other treatments?
The tACS (transcranial alternating current stimulation) treatment for aphasia after stroke is unique because it uses electrical currents at specific frequencies (10-Hz and 40-Hz) to potentially enhance brain function, unlike traditional speech and language therapy or tDCS (transcranial direct current stimulation), which uses constant electrical currents. This approach may offer a novel way to improve language abilities by targeting brain activity patterns differently.678910
What data supports the effectiveness of the treatment tACS for aphasia after stroke?
Research shows that non-invasive brain stimulation methods like transcranial direct current stimulation (tDCS) can help improve language skills in people with aphasia after a stroke. These methods, when combined with speech therapy, have shown promise in enhancing recovery by promoting brain plasticity (the brain's ability to adapt and change).511121314
Who Is on the Research Team?
Priyanka Shah-Basak, PhD
Principal Investigator
Medical College of Wisconsin
Are You a Good Fit for This Trial?
This trial is for adults who have had a stroke and are experiencing language difficulties (aphasia), as well as healthy adults without neurological issues. Participants must be fluent in English, at least 18 years old, and right-handed if they've had a stroke. They can't join if they have severe sensory impairments, untreated psychiatric diseases, unstable medical conditions, metal implants in the skull, or history of seizures or dyslexia.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo HD-tACS at 10 Hz or 40 Hz, or sham-tACS, combined with language tasks and EEG monitoring
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- tACS 10-Hz
- tACS 40-Hz
- tACS sham
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical College of Wisconsin
Lead Sponsor